Oncogenic Ras and constitutively activated Akt promote multiple myeloma cell survival independently of each other

被引：0
|
作者：
Steinbrunn, T. [1 ]
Stuehmer, T. [1 ]
Chatterjee, M. [1 ]
Gattenloehner, S. [2 ]
Einsele, H. [1 ]
Bargou, R. [1 ]
机构：
[1] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
[2] Univ Klinikum Wurzburg, Inst Pathol, Wurzburg, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：282 / 283
页数：2
相关论文
共 38 条
  • [31] Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival
    Carón, RW
    Yacoub, A
    Li, M
    Zhu, XY
    Mitchell, C
    Hong, Y
    Hawkins, W
    Sasazuki, T
    Shirasawa, S
    Kozikowski, AP
    Dennis, PA
    Hagan, MP
    Grant, S
    Dent, P
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (02) : 257 - 270
  • [32] Oncogenic H-Ras and PI3K Signaling can Inhibit E-Cadherin-Dependent Apoptosis and Promote Cell Survival After Photodynamic Therapy in Mouse Keratinocytes
    Espada, Jesus
    Galaz, Sergio
    Sanz-Rodriguez, Francisco
    Blazquez-Castro, Alfonso
    Carlos Stockert, Juan
    Bagazgoitia, Lorea
    Jaen, Pedro
    Gonzalez, Salvador
    Cano, Amparo
    Juarranz, Angeles
    JOURNAL OF CELLULAR PHYSIOLOGY, 2009, 219 (01) : 84 - 93
  • [33] Group I p21-Activated Kinases (PAKs) Promote Tumor Cell Proliferation and Survival through the AKT1 and Raf-MAPK Pathways
    Menges, Craig W.
    Sementino, Eleonora
    Talarchek, Jacqueline
    Xu, Jinfei
    Chernoff, Jonathan
    Peterson, Jeffrey R.
    Testa, Joseph R.
    MOLECULAR CANCER RESEARCH, 2012, 10 (09) : 1178 - 1188
  • [34] Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival
    Xin, H
    Geng, YB
    Pramanik, R
    Choubey, D
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 88 (01) : 191 - 204
  • [35] SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK
    Okawa, Yutaka
    Hideshima, Teru
    Steed, Paul
    Vallet, Sonia
    Hall, Steven
    Huang, Ken
    Rice, John
    Barabasz, Amy
    Foley, Brianna
    Ikeda, Hiroshi
    Raje, Noopur
    Kiziltepe, Tanyel
    Yasui, Hiroshi
    Enatsu, Sotaro
    Anderson, Kenneth C.
    BLOOD, 2009, 113 (04) : 846 - 855
  • [36] The PI3K/Akt signaling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival in multiple myeloma
    Chatterjee, Manik
    Andrulis, Mindaugas
    Stuehmer, Thorsten
    Mueller, Elisabeth
    Hofmann, Claudia
    Steinbrunn, Torsten
    Heimberger, Tanja
    Schraud, Heike
    Kressmann, Stefanie
    Einsele, Hermann
    Bargou, Ralf C.
    HAEMATOLOGICA, 2013, 98 (07) : 1132 - 1141
  • [37] P21-ACTIVATED KINASE 4 (PAK4) REGULATES MULTIPLE MYELOMA (MM) CELL GROWTH AND SURVIVAL BY MODULATION OF CRITICAL TRANSCRIPTIONAL PATHWAYS: THERAPEUTIC APPLICATION OF PAK4 ALLOSTERIC INHIBITORS
    Fulciniti, M. T.
    Oliva, S.
    Amodio, N.
    Roccaro, A.
    Bandi, R. L.
    Daisy, H.
    Cagnetta, A.
    Senapedis, W.
    Baloglu, E.
    Anderson, K. C.
    Ghobrial, I.
    Munshi, N. C.
    HAEMATOLOGICA, 2015, 100 : 78 - 79
  • [38] Activated O2•- and H2O2 Mediated Cell Survival in SU11274-Treated Non-Small-Cell Lung Cancer A549 Cells via c-Met-PI3K-Akt and c-Met-Grb2/SOS-Ras-p38 Pathways
    Liu, Ying
    Shi, Qi-Feng
    Ye, Yuan-Chao
    Tashiro, Shin-ichi
    Onodera, Satoshi
    Ikejima, Takashi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 119 (02) : 150 - 159
1234